ST. PAUL, Minn.--(BUSINESS WIRE)--Feb. 7, 2005--BioE(R), Inc., a biotechnology company developing antibody-based technology platforms for therapeutic and diagnostic applications, announced today it has received $8.3 million in its latest round of private financing. Since 1998, BioE has raised more than $22 million, solely from angel investors.
